| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |